COCP
COCP
NASDAQ · Pharmaceuticals

Cocrystal Pharma Inc

$1.06
+0.03 (+2.91%)
As of Aug 8, 10:55 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,534.0% upside
Low Target $19.61
Average Target $27.92
High Target $38.36
Current Price $1.06
Current
$1.06
Target
$27.92
$19.61 $27.92 avg $38.36
Scenario Analysis
Bear Case
$19.61
1,750.0%
Low target
Base Case
$27.92
+2,534.0%
Avg target
Bull Case
$38.36
+3,518.9%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.67
-60.3% from high
52-Week Low
$0.76
+39.5% from low
Target vs 52W High
$27.92
+945.7% vs high
Next Earnings Report
Aug 17, 2026
7d
until earnings
EPS Est: $-0.17
Earnings in 7 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +12.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +15.5%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +23.9%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +26.7%
BMY
Bristol-Myers Squibb Co
Hold 35 40% $174.50 +169.6%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -36.1%
ZTS
Zoetis Inc
Hold 24 54% $209.87 +188.8%